Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Editorial
EDITORIAL BOARD
Editorial I
Editorial II
Original Article
Review
Review Article
Systematic Review
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Case Series
Editorial
EDITORIAL BOARD
Editorial I
Editorial II
Original Article
Review
Review Article
Systematic Review
View/Download PDF

Translate this page into:

Original Article
19 (
5
); 25-33
doi:
10.25259/OJS_8956

The influence of sarcopenia measures on balance performance based on the timed-up and go test in older adults residing in the community

Center for Physiotherapy Studies, Faculty of Health Sciences, Universiti Teknologi MARA Selangor, Puncak Alam Campus, Puncak Alam, Selangor, Malaysia
Department of Physiotherapy, School of Allied Sciences, Cyberjaya College, Kota Kinabalu, Sabah, Malaysia,
Department of Physical Therapy, Faculty of Allied Health Sciences, Chulalongkorn University, Thailand

*Corresponding author: Maria Justine, Centre for Physiotherapy Studies, Faculty of Health Sciences, Universiti Teknologi MARA, Selangor, Malaysia. maria205@uitm.edu.my

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Openg AJ, Zahari Z, Siriphorn A, Justine M. The influence of sarcopenia measures on balance performance based on the timed-up and go test in older adults residing in the community. Int J Health Sci (Qassim). 2025;19(5):25-33. doi: 10.25259/OJS_8956

Abstract

Objectives:

Sarcopenia has been hypothesized to affect balance and increase fall risk. This study investigated the influence of sarcopenia measures on balance performance, assessed using the timed-up and go test (TUG), in community-dwelling older adults.

Methods:

This cross-sectional study recruited 315 older adults aged ≥60 years (mean age = 68.02 ± 5.88) from selected communities in Selangor, Malaysia. Assessment included Strength, Assistance in walking, Rising from a chair, Climbing stairs, and Falls (SARC-F) questionnaire (5-items: Strength, assistance in walking, rising from a chair, climbing stairs and falls), muscle mass (MM) (Bioelectrical impedance analysis), muscle strength (MS) (grip dynamometer), and physical performance (PP) (5-times chair stand). Balance performance was assessed using the TUG test, which measures balance through combined movements including walking and turning.

Results:

About 182 (58.78%) and 133 (42.22%) participants showed low and normal balance performance, respectively. Chi-square tests indicated that MM (P = 0.043), SARC-F, MS, and PP (all P < 0.01) differed significantly between groups. Unadjusted logistic regression analysis showed balance performance was significantly associated with SARC-F (odds ratio [OR]: 0.4 [95% confidence interval (CI): 0.33, 0.48]), MS (OR: 1.06 [95% CI: 1.04, 1.09]), and PP (OR: 0.77 [95% CI: 0.71, 0.82]). In the adjusted model (age and gender), SARC-F, MS, and PP remained significantly associated with balance performance, including MM (OR: 0.60 [95% CI: 0.50, 0.73]), indicating those with low balance performance have a higher risk of sarcopenia with lower MS, MM, and PP.

Conclusion:

Sarcopenia may influence balance in older adults. Early screening with the SARC-F tool may help detect sarcopenia, while continued research on targeted interventions could reduce fall risk in this population.

Keywords

Aged
Balance
Muscular disorder
Older adults
SARC-F

INTRODUCTION

The United Nations, Department of Economic and Social Affairs (2017)[1] projects that the number of older adults will increase from 962 million in 2017 to 2.1 billion by 2050.[1,2] One of the prominent implications associated with an aging population is the events of fall.[3] A recent systematic review revealed a global prevalence of falls in older adults, with the majority of fall incidents occurring among individuals aged 54–87, indicating an elevated risk of falls in the future.[4] The World Health Organization defines a fall as the unintentional coming to rest on the ground, floor, or a lower level, excluding intentional changes in position to rest on furniture, walls, or other objects.[5] In simpler terms, a fall occurs when an individual accidentally and sometimes traumatically ends up on the floor or at a lower level.[6] In addition, evidence suggested that other factors that most likely cause falls, including muscle strength (MS) and gait, could cause impairment to balance performance.[7] Balance refers to the ability of an individual to maintain their center of gravity within the base of support while reacting to a sudden disturbance triggered by external or internal factors, and is important for daily activities such as walking, standing, and even sitting.[8]

As aging occurs, individuals will start to experience physiological changes, including the reduction of muscle mass (MM), which will likely affect their daily living activities, including balance function, especially during movement such as sit-to-stand and walking. Sarcopenia, an age-related loss of MM, is a progressive and generalized skeletal muscle disorder that affects MM, strength, and physical performance (PP),[9] which also happens to be associated with factors that influence an individual’s balance that may lead to a fall.[10,11] The previous studies have largely focused on the association between sarcopenia and falls in older adults, often through systematic reviews and meta-analyses.[12,13] However, critical gaps in the literature suggest further exploration is needed. One key issue is the inconsistency in sarcopenia definitions and assessment methods across the studies. For instance, Zhang et al.[14] highlighted that various studies have diagnosed sarcopenia using different criteria, including those from the European Working Group on Sarcopenia in Older People, the Foundation for the National Institutes of Health, and the Asian Working Group for Sarcopenia (AWGS), making it challenging to compare findings. Since cut-off points depend on measurements obtained from various instruments that may not be readily accessible, a simple questionnaire was proposed as an alternative for sarcopenia screening.[15] The SARC-F is widely recognized for its efficiency and alignment with multiple diagnostic algorithms and incorporates MM, MS, and PP measures, as recommended by most of the working group for sarcopenia, including the latest AWGS criteria.[12] SARC-F is a 5-item questionnaire that assesses sarcopenia based on participants’ perceptions of their strength, walking ability, rising from a chair, stair-climbing, and falls. SARC-F is believed to have good validity and consistency in identifying people at risk of sarcopenia.[9] Apart from its simplicity and being well recognized among different countries, it measures the most crucial movements relating to balance in combination with the other tools, including MM, strength, and PP as recommended by the AWGS. Thus, SARC-F may potentially be associated with individuals’ balance performance.

Sarcopenia causes a loss of MM and strength, which further causes impairments to one’s balance performance. These issues, in turn, can raise the risk of falling. Thus, exploring the correlation of sarcopenia parameters with balance performance is crucial to better understand and address this important public health issue. Since most of the country is predicted to reach aging nations in the near future, thus, determining how sarcopenia can affect balance is crucial to tackle this issue by empowering more research to understand the influence and how to prevent the risk of falls in the older population.

Hence, the primary objective of the present study is to explore the influence of sarcopenia measures on balance performance in older adults residing in the community.

MATERIALS AND METHODS

This is a cross-sectional study where the sample population was recruited from Bangi, Kajang, Semenyih, Hulu Selangor, Beranang, and Sabak Bernam in Selangor, Malaysia, using purposive sampling. The sample size calculation was conducted using G*Power 3.1.9.2 for an Analysis of covariance statistical test with fixed effects, main effects, and interactions. An effect size of 0.25, representing a medium effect size per Cohen’s guidelines, was chosen to balance statistical power and feasibility in community settings. The significance level (a) was set at 0.05, with a statistical power (1 - b) of 0.90 to ensure a 90% probability of correctly rejecting the null hypothesis. The sample size calculation yielded that about 338 participants are required to detect a medium effect size with high confidence and precision.

Participants underwent initial eligibility screening based on the predetermined criteria. The inclusion criteria were people aged 60 and above, of both genders, with no recent acute illnesses (such as a stroke or Parkinson’s disease within the past 6 months) and no cognitive impairment (based on a Mini-Cog test score of >4). The exclusion criteria were significant hypertension (systolic >180 at the time of evaluation), inability to comprehend the study procedures, a history of heart problems, gastrointestinal tract disease, musculoskeletal injuries (such as bone fractures or sprains within the past 6 months), and recent surgery (within the past 6 months).

Participants who met the inclusion criteria proceeded to the data collection procedures. This phase began with the completion of self-reported questionnaires. Participants answered the SARC-F questionnaire to assess sarcopenia-related symptoms, with provided assistance mainly to those who required help due to reading difficulties or other impairments. The research ethical approval for a study involving human subjects was obtained from the Research Ethics Committee, UiTM (Approval Number: REC/02/2021 (MR/81). Participants’ consent to participate and for data publication in a journal article was obtained before data collection.

Data collection

Participants in the study gave their consent and completed questionnaires with demographic information and a self-administered questionnaire about the aspects related to their general health status. The Mini-Cog test was also used to assess the participants’ cognitive functions.[16] Body mass index (kg/m2) was calculated by dividing participants’ body weight (kg) by the square of their height (m2).

Sarcopenia assessment

In this study, sarcopenia assessment followed a structured approach, beginning with screening using the SARC-F questionnaire, followed by the evaluation of three key sarcopenia components: MM, MS, and PP.

Screening with SARC-F

This study utilized the SARC-F questionnaire as an initial screening tool to assess sarcopenia risk among participants, focusing on self-reported functional limitations. SARC-F has been shown to have good validity and consistency in identifying people at risk of sarcopenia.[9] This questionnaire is simple and can save time by subjectively identifying sarcopenia symptoms in sarcopenic individuals.[12]

MM measurement

Bio-electrical impedance analysis (BIA) is a non-invasive tool that can evaluate body composition and provide validated results for a large population in a short time.[17] For determination of MM, the lean mass of each limb (both arms and legs) with a segmental measure was evaluated. Then, the lean masses from all four limbs were summed up to get the Appendicular Skeletal Muscle Mass (ASM) value. To standardize this measure and account for height differences, ASM was divided by height squared (ASM/height) to obtain the appendicular skeletal muscle mass index (ASMI). The absolute MM of a person is highly correlated with height and may influence the results.[18] Thus, height squared in the formula was used to convert the absolute MM to ASMI, minimizing the correlation of the index of the height index across different study populations.[18]

MS measurement

MS was measured based on their grip strength using the Jamar dynamometer, a well-validated and reliable measure of MS.[18] The procedure requires the participants to sit on an armless chair with their hips and knees at 90°. The participants hold the Jamar dynamometer with the elbow at 90°, forearm neutral, and wrist at 15–30° extension and 0–15° ulnar deviation.[19] The highest recorded value from either both hands or the dominant hand during a maximum force isometric contraction was used for analysis.[12]

PP assessment

The 5-time chair stand was utilized to assess the PP of the participants, which is often used as a substitute for gait speed assessment.[12] This approach is a reliable and valid clinical tool for measuring lower extremities and has high test-retest reliability.[20] The sit-to-stand movement was used in the test, where participants were required to stand up 5 times repeatedly from a seated position with their arms folded over their chest. On the fifth repetition, the time measured from the “go” signal until the participants’ buttocks touched the chair was recorded. A time exceeding 12 s, corresponding to a gait speed of 1.0 m/s, suggests a decline in PP. Recorded time of more than 12 s, corresponding to a gait speed of 1.0 m/s, indicating a loss in PP.[11]

Balance performance

Meanwhile, the timed-up and go test (TUG) was used to indicate the balance performance or risk of falling. TUG is a quick and easy-to-administer test that showed a good sensitivity toward changes, as well as having a good inter-rater and test-retest reliability (intraclass correlation [ICC] = 0.98).[21,22] The TUG was used in the present study because it captures multiple components of mobility in a single assessment, including the transition from sitting to standing, performance during walking in a straight line, turning, before coming to a sitting position again, which makes it a more comprehensive measure. In addition, TUG is sensitive to detecting balance impairments and changes over time, making it useful for screening and monitoring interventions. This test was performed by instructing the participants to rise from a standard armchair and walk a distance of 3 m at a normal and safe pace, followed by turning around, walking back to the chair, and sitting down again. Assistive devices (e.g., canes) were allowed to be used during the test. The time needed to perform the TUG was measured twice in seconds using a stopwatch, whereby the faster-timed trial was used as the final score. Participants who took more than 14 s on the TUG test were considered at high risk of falling or poor balance performance.[23,24]

Data analysis

The data were analyzed using the Statistical Package for the Social Sciences (SPSS) for Windows version 25 (SPSS Version 25, IBM Corp, New York, NY, USA). The normality tests were done using the Kolmogorov-Smirnov test. Descriptive data were described as mean, standard deviation (SD), frequency, and percentage.

An Independent t-test for interval and Chi-square tests for categorical data were used to compare the sarcopenia parameters between participants with normal and low balance performance. To determine the association between balance performance and sarcopenia parameters, the binary logistic regression analysis was conducted for unadjusted and adjusted (controlling for the effects of age and gender).[25] The level of significance was maintained at P < 0.05.

Several confounding factors were considered in this study, including age and gender, both of which are known to influence sarcopenia and fall risk. Age is a primary risk factor, as MM and strength naturally decline with aging, increasing the likelihood of both sarcopenia and falls.[26] Gender was also identified as a potential confounder, as women generally have lower MM and strength than men and are at a higher risk of falls.[9] Therefore, gender may impact the relationship between sarcopenia and fall risk. To account for these confounding effects, the analysis was conducted twice; first without adjustment for age and gender, and then with adjustment for these covariates to better isolate the association between sarcopenia and falls.

RESULTS

Table 1 summarizes the overall participants’ characteristics. The total sample size was 315, which included 167 females (53%) and 148 males (47%). The mean age was 68.05 years (SD = 5.98), ranging from 60 to 90 years old. About 133 (42.2%) of participants presented with low balance performance.

Table 1: Characteristics of study participants (n=315).
Characteristics Frequency, n Percentage
Age, median (Mean SD: 68.05±5.98) - -
Height (cm) (Mean SD: 159.09±8.23) - -
Weight (kg) (Mean SD: 69.54±13.18) - -
Body mass index (kg/m2) (Mean SD: 27.41±4.53) - -
Gender
  Female 167 53.0
  Male 148 47.0
Ethnicity
  Malay 231 71.3
  Chinese 50 15.4
  India 34 10.5
Comorbidities
  Yes 264 81.5
  No 51 15.7
Smoking status
  Yes 51 16.2
  No 264 83.8
Alcohol intake
  Yes 37 11.7
  No 278 88.3
Surgery
  Yes 50 15.9
  No 265 84.1
Vision
  Normal 123 39.0
  Abnormal 192 61.0
Polypharmacy
  Yes 210 66.7
  No 105 33.3
Balance performance (Mean SD: 14.39±6.39)
  Normal 133 42.2
  Low 182 57.8

Values are presented as frequency, n(%), and mean±SD. SD: Standard deviation

Table 2 shows the result of the independent t-tests for the mean differences and the Chi-square test for frequency differences of sarcopenia parameters between participants with low and normal balance performance. The independent t-tests show that all sarcopenia parameters are significantly different between participants with normal and low balance performance (All P < 0.05), except for MM (P = 0.057). On the other hand, the results for the Chi-square tests indicate that all sarcopenia parameters are significantly different between participants with low and normal balance performance.

Table 2: Comparison of sarcopenia parameters between participants with normal and low balance performance.
Variables Reference values for possible sarcopenia Balance performance (n=315)
Low (n=182) Normal (n=133) P-value
SARC-F ≥4 3.84±1.86 1.17±1.39 0.001a**
Normal 50 174 0.010b*
Possible sarcopenia 78 13
Muscle strength (kg) 20.19±8.35 25.99±10.70 0.001a*
Normal Men: <28 kg 59 131 0.001b**
Low Women: <18 kg 69 56
Muscle mass (kg/m2) 7.44±1.66 7.08±1.63 0.057
Normal Men: <7.0 kg/m2 29 62 0.043b
Low Women: <5.7 kg/m2 99 125
Physical performance (m/s) 18.23±7.19 12.91±3.84 0.001a**
Normal >14 s 9 80 0.001b**
Low 119 107

SARC-F: Strength, Assistance in walking, Rising from a chair, Climbing stairs, and Falls, Values are presented as frequency, n(%) and mean±standard deviation. **significant at P<0.001, *Significant at P<0.04 based on aIndependent t-test and bChi-square test

Table 3 describes the results of the binary logistic regression analysis. Data were presented analyzed through the values of odd ratio (OR) and confidence interval (CI).

Table 3: Logistic regression analysis of balance performance and sarcopenia parameters.
Variable Unadjusted (n=315) Adjusted (age and gender) (n=315)
B S.E. Wald df Sig. OR 95% CI B S.E. Wald df Sig. OR 95% CI
SARC-F −0.92 0.10 84.67 1 0.001** 0.40 0.33, 0.48 -1.16 0.14 67.68 1 0.001** 0.31 0.24, 0.41
Muscle mass −0.13 0.07 3.58 1 0.058 0.87 0.76, 1.00 -0.51 0.10 24.44 1 0.001** 0.60 0.50, 0.73
Muscle strength 0.06 0.01 22.87 1 0.001** 1.06 1.04, 1.09 0.08 0.02 17.40 1 0.001** 1.08 1.04, 1.13
Physical performance −0.27 0.04 52.48 1 0.001** 0.77 0.71, 0.82 -0.28 0.04 38.75 1 0.001** 0.76 0.69, 0.83

B: Regression coefficient, S.E.: Standard error of the coefficient, df: Degrees of freedom, Sig.: Significance level ,OR: Odd ratio, CI: Confidence interval, SARC-F: Strength, Assistance in walking, Rising from a chair, Climbing stairs, and Falls. **Significant at P<0.01

For SARC-F, both models show a strong, significant negative association (unadjusted OR = 0.40; adjusted OR = 0.313), indicating higher SARC-F scores significantly decrease the odds of better balance performance. MM is non-significant in the unadjusted model (OR = 0.87, P = 0.058) but significant in the adjusted model (OR = 0.60), indicating lower MM reduces the likelihood of better balance. Muscle strength is positively significant associated in both models (unadjusted OR = 1.063; adjusted OR = 1.08), which means higher muscle strength increases the odds of better balance performance. PP shows a significant negative association across models (unadjusted OR = 0.77; adjusted OR = 0.76), describing poorer PP reducing balance performance. Except for MM, all outcomes were significantly associated with TUG, with P < 0.01.

DISCUSSION

In the present study, findings showed that among various measures of sarcopenia, only SARC-F, muscle strength, and PPs were independent predictors of falls among older individuals living in the community. However, after controlling for the effects of age and gender, all sarcopenia parameters were associated with balance performance, which includes MM.

Notably, SARC-F was highly correlated to balance performance, suggesting that it can be used as a straightforward screening measure for both sarcopenia and balance performance.[27] Similarly, our study revealed the association of SARC-F to balance performance as assessed through TUG (OR: 0.4 [95% CI: 0.33,0.48]). SARC-F’s validity and consistency in identifying individuals at risk of sarcopenia have been documented,[12] making it an efficient tool for case finding. It was also found that SARC-F score of 4 or higher independently predicts fall risk with a sensitivity of 44.44% and a specificity of 89.26%, although with the use of different balance assessment tools.[27] Thus, integrating SARC-F could be beneficial in indirectly measuring changes in an individual’s balance performance in a short time. While SARC-F is an efficient tool for detecting sarcopenia symptoms within a short time, its reliance on subjective self-reporting poses a risk of bias. Therefore, it is recommended to combine SARC-F with objective assessment tools, such as muscle strength and PP measures, to enhance accuracy and reliability.

Muscle strength emerged as a critical factor impacting both dynamic and static balance and was identified as a significant predictor of fall risk in older adults.[28] Individuals at high risk of falls exhibited lower muscle strength and poorer PP compared to those at low risk, as supported in the previous studies.[29] These findings highlight the importance of maintaining muscle strength and overall physical fitness to prevent falls. Improving muscle strength through targeted exercises, balance training, and resistance training may help to improve their balance and reduce the risk of falls.[30]

Muscle health, including MM, strength, and PP, emerged as significant factors associated with falls. Individuals at high fall risk displayed lower muscle strength and poorer PP, reiterating the significance of maintaining muscle strength and overall fitness to prevent falls. Older adults will slowly encounter a reduction of muscle strength, which causes them to have difficulties in movement.[31] As individuals age, they will likely experience a decline in MM, which also impacts their muscle strength.[32,33] This decline in strength is primarily attributed to a reduction in Type-II muscle fibers, also known as fast-twitch fibers, which are responsible for generating muscle tension. These fibers are larger and contract more quickly, thus contributing to an individual’s overall strength.[34,35] However, our study did not include a specific assessment to directly evaluate muscle fiber reduction, limiting our ability to confirm this aspect. Despite that, measuring muscle strength is encouraged to assess outcomes or predict potential limitations that may interfere with daily activities, as its decline has been identified as an independent predictor of poor balance performance in our study (OR: 1.06 [95% CI: 1.04, 1.09]).

PP was observed to have an association with balance performance.[36,37,39] Physical performance encompasses objectively measured whole-body functions related to locomotion,[9] where the 5 times sit-to-stand test was employed in this study. It is a reliable and valid clinical tool to gauge lower extremity strength and their overall performance.[20] Sarcopenia involves physiological and functional deterioration, including PP,[9] which may increase the fall-related aspects. The reduction in MM can lead to diminished muscle strength and affect limb proprioception, disrupting balance mechanisms and influencing an individual’s PP.[10] Often, physical performance is related to the ability to sustain impact on the lower limbs, making most of the variables used involve gait speeds.[12] PP is also critically related to muscle strength, which contributes to the fall-related aspects as it works to maintain balance and stability, where weaker muscles can compromise an individual’s ability to react to sudden changes in posture or prevent a fall. Thus, a reduction in physical performance has consistently influenced balance performance in older adults.[9]

It is noted that sarcopenia involves negative changes in skeletal MM, strength, and PP,[12] contributing to adverse outcomes including reduced balance performance and increased fall risk.[38,39] However, the present study observed a lack of association between sarcopenia based on MM measured using the BIA with fall incidence. This might be due to the methodological variation, where other study implies the usage of other high-advanced tools such as dual-energy x-ray absorptiometry, which have better sensitivity when measuring MM. Intriguingly, the study found that participants at high fall risk had higher MM, potentially indicating a complex relationship between increased MM and falls, which might involve factors such as muscle quality and overall physical fitness.

Another aspect that needs to be focused on when relating sarcopenia with balance performance is neuromuscular control, which plays a crucial role in maintaining postural stability, muscle function, and movement coordination. As aging and sarcopenia occur, they significantly affect the components required to ensure a good balance performance, including weakened muscle responses, impaired balance, and increased fall risk.[12,40] The decline in neuromuscular function is influenced by multiple factors, including the loss of motor units, reduced proprioception, and hormonal changes.[41]

Aging causes numerous hormonal and neuronal changes, implying that multiple genes must be differentially expressed.[40] This results in decreased hypothalamic and peripheral receptor sensitivity, leading to energy imbalances, immune system weakening through immunosenescence, reduced reproductive ability, and diminished physiological adaptability.[41] In addition, the reduction in sex-related hormone secretion, such as estrogen after menopause, is associated with osteoporosis, further contributing to decreased muscle strength and movement ability.[42]

Physiological changes with advancing age are characterized by a decline in both the size and number of muscle fibers, particularly Type II (fast-twitch) fibers, which are responsible for quick, powerful contractions.[34,35] Type II muscle fibers are essential for strength and rapid force generation, and their reduction leads to decreased neuromuscular efficiency, slower reaction times, and impaired postural control.[43] Satellite cells, which play a critical role in muscle regeneration, also decline with age, reducing the ability to repair and regenerate muscle fibers.[44] The loss of these cells further impairs neuromuscular function, slowing the signal conduction between muscle bundles and compromising overall muscle strength and coordination.[45]

As the loss of MM progresses, individuals also experience a reduction in muscle strength, primarily due to the deterioration of Type II fibers, which are essential for performing movements against resistance.[46] With fewer motor units available to innervate muscles, neuromuscular transmission weakens, leading to diminished movement efficiency and a greater reliance on compensatory mechanisms to maintain balance. In addition, proprioception, the body’s ability to sense movement and spatial positioning, deteriorates with aging, affecting neuromuscular control and balance regulation. Sensory degradation in muscle spindles and joint receptors slows neuromuscular responses, increasing postural sway and fall risk.[34]

Given the critical role of neuromuscular control in maintaining balance and mobility, targeted interventions such as resistance training, balance exercises, and neuromuscular stimulation therapies should be implemented into the clinical practice to enhance muscle activation and functional connectivity.

Physical inactivity is a significant risk factor for the deterioration of musculoskeletal health, as well as for the increased risk of non-communicable diseases, including sarcopenia.[47] Therefore, promoting an active lifestyle, particularly among the older population, is essential to maintaining stable balance performance. Muscle fatigue too can notably impair PP, which, in turn, affects balance and increases the risk of falls in older adults. A study found that expectations regarding supplementation (such as caffeine or lactic acid) could influence perceived exertion and endurance, indicating that psychological factors also contribute to performance outcomes.[48]

Another important factor influencing balance performance is low Vitamin D levels, which are associated with an increased risk of various health issues, including cardiovascular disease.[49] However, Vitamin D was not measured in the present study. Since Vitamin D plays a critical role in muscle function and bone health, it is recommended that future research includes Vitamin D assessments to explore how deficiencies may exacerbate sarcopenia and elevate fall risk among older adults.

Knee osteoarthritis (OA)-related pain is another major factor affecting balance performance. This condition is widespread among older adults and significantly impairs both balance and mobility. Knee OA often results in generalized pain, swelling, and stiffness, which can disrupt balance and increase the risk of falls. It is therefore crucial to consider knee OA as a variable in future studies.[50]

The limitations of this investigation highlighted the small sample size of the study, initially posing a challenge that made it difficult to categorize participants accurately according to their severity levels. Because measurements were made at a single moment in time, the cross-sectional design of this study made it impossible to determine a cause-and-effect link between sarcopenia indices and balance performance. To fully comprehend the causal-and-effect link between these factors and to determine strategies for addressing and preventing falls in the future for older populations, it is highly recommended that more longitudinal data reflective of sarcopenia and balance performances be included. Finally, this study highlights the importance of including sarcopenia markers in fall assessments, such as the use of SARC-F and measurements of MM, strength, and PP. However, it is essential to ensure comprehensive training for those conducting these assessments, as improper execution could affect the outcomes.[51]

CONCLUSION

The present study shows that sarcopenia parameters, particularly SARC-F, muscle strength, and PP are significantly associated with balance performance in older adults, with MM only significantly associated after controlling for age and gender. The current findings suggest that early screening of sarcopenia parameters, mainly muscle strength and PP may potentially enhance balance performance in older adults. Future studies should explore the longitudinal impacts of intervention to confirm their effectiveness in balance improvement and fall risk reduction in the older population.

Acknowledgments:

The authors would like to thank all individuals and institutions who supported this research directly or indirectly.

Authors’ contributions:

AJ and MJ: Responsible for screening studies for review based on title and abstract, and were the major contributors in writing the manuscript; AJ and MJ: Participate actively in designing the study and performing the statistical analysis; ZZ and AS: Responsible for screening studies for full review and made critical revisions to the manuscript. All authors read and approved the final manuscript.

Ethical approval:

The Institutional Review Board ethical approval was obtained from the Research Ethics Committee, UiTM (Approval Number: REC/02/2021 (MR/81), dated February 24, 2021.

Declaration of patient consent:

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest:

There are no conflicts of interest.

Availability of data and materials:

The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.

Financial Support and Sponsorship: The study was supported by the Universiti Teknologi MARA (UiTM) through the GERAN PENYELIDIKAN KHAS (Project Code: 600-U/GPK 5/3 [073/2020]).

References

  1. . Department of Economic and Social Affairs PD, Population. . Available from: https://www.un.org/en/development/desa/population/publications/pdf/ageing/wpa2017_highlights.pdf [Last accessed on 2025 Apr 21]
    [Google Scholar]
  2. . Ageing. . World Health Organization. Available from: https://www.who.int/health-topics/ageing#tab=tab_1 [Last accessed on 2022 Sep 05]
    [Google Scholar]
  3. , , , , , , et al. Sarcopenia and sarcopenic obesity in Spanish community-dwelling middle-aged and older women: Association with balance confidence, fear of falling and fall risk. Maturitas. 2018;107:26-32.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , . Global prevalence of falls in the older adults: A comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2022;17:334.
    [CrossRef] [PubMed] [Google Scholar]
  5. . WHO global report on falls prevention in older age. . World Health Organization. Available from: https://www.who.int/ageing/projects/falls_prevention_older_age/en/index.html [Last accessed on 2025 Apr 21]
    [Google Scholar]
  6. , , , , , , et al. Falls among older adults: Screening, identification, rehabilitation, and management. Appl Sci. 2022;12:7934.
    [CrossRef] [Google Scholar]
  7. , . What are the main risk factors for falls amongst older people and what are the most effective interventions to prevent these falls? . World Health Organization. :28. Available from: https://scholar.google.com/scholar?hl=en&btng=search&q=intitle:what+are+the+main+risk+factors+for+falls+amongst+older+people+and+what+are+the+most+effective+interventions+to+prevent+these+falls [Last accessed on 2025 Apr 21]
    [Google Scholar]
  8. , , , , , . Assessing elderly's functional balance and mobility via analyzing data from waist-mounted tri-axial wearable accelerometers in timed up and go tests. BMC Med Inform Decis Mak. 2021;21:108.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , , , , , et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16-31.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , , , , et al. The prevalence of sarcopenia in fallers and those at risk of falls in a secondary care falls unit as measured by bio-impedance analysis. J Frailty Sarcopenia Falls. 2018;3:128-31.
    [CrossRef] [PubMed] [Google Scholar]
  11. , . The patient who falls: “It's always a trade-off”. JAMA. 2010;303:258-66.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , , , , et al. Asian working group for sarcopenia: 2019 Consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-7.e2.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , et al. Epidemiology of sarcopenia among the elderly in new Mexico. Am J Epidemiol. 1998;147:755-63.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Falls among older adults with sarcopenia dwelling in nursing home or community: A meta-analysis. Clin Nutr. 2020;39:33-9.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , . Validating the SARC-F: A suitable community screening tool for sarcopenia? J Am Med Dir Assoc. 2014;15:630-4.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , , , . Utility of the mini-cog for detection of cognitive impairment in primary care: Data from two Spanish studies. Int J Alzheimers Dis. 2013;2013:285462.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , . Validity of bioelectrical impedance analysis to estimation fat-free mass in the army cadets. Nutrients. 2016;8:121.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. Sarcopenia and falls in community-dwelling elderly subjects in Japan: Defining sarcopenia according to criteria of the European working group on sarcopenia in older people. Arch Gerontol Geriatr. 2014;59:295-9.
    [CrossRef] [PubMed] [Google Scholar]
  19. , . Differences in handgrip strength protocols to identify sarcopenia and frailty-a systematic review. BMC Geriatr. 2017;17:238.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. Predictive cutoff values of the five-times sitto-stand test and the timed “up and go” test for disability incidence in older people dwelling in the community. Phys Ther. 2017;97:417-24.
    [Google Scholar]
  21. , , , . Reliability, validity, and responsiveness of three scales for measuring balance in patients with chronic stroke. BMC Neurol. 2018;18:141.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , . Select physical performance measures and driving outcomes in older adults. Inj Epidemiol. 2017;4:14.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , . Predicting the probability for falls in community-dwelling older adults using the timed up and go test. Phys Ther. 2000;80:896-903.
    [CrossRef] [PubMed] [Google Scholar]
  24. , . The timed “up and go”: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-8.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , . Risk factors for falls among older adults: A review of the literature. Maturitas. 2013;75:51-61.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , , et al. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin Nutr. 2012;31:652-8.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , , , et al. SARC-F and the risk of falling in middle-aged and older community-dwelling postmenopausal women. Int J Environ Res Public Health. 2021;18:11570.
    [CrossRef] [PubMed] [Google Scholar]
  28. , . Falls in older women and men: Associated factors and sarcopenia. Eur J Geriatr Gerontol. 2023;5:124-31.
    [CrossRef] [Google Scholar]
  29. , , , , . Relationship between fear of falling and balance factors in healthy elderly women: A confirmatory analysis. J Women Aging. 2019;33:57-69.
    [CrossRef] [PubMed] [Google Scholar]
  30. , . Impact of balance and fear of fall in patients with sarcopenia. Int J Health Sci Res. 2016;6:230-7.
    [Google Scholar]
  31. , , , , , , et al. Effectiveness of exercise and protein supplementation intervention on body composition, functional fitness, and oxidative stress among elderly Malays with sarcopenia. Clin Interv Aging. 2013;8:1365-75.
    [CrossRef] [PubMed] [Google Scholar]
  32. , , , , , , et al. Prevalence of fear of falling and associated factors among Japanese community-dwelling older adults. Medicine (Baltimore). 2018;97:e9721.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , , , , et al. Age-associated declines in muscle mass, strength, power, and physical performance: Impact on fear of falling and quality of life. Osteoporos Int. 2016;27:463-71.
    [CrossRef] [PubMed] [Google Scholar]
  34. . Sarcopenia in older adults. Curr Opin Rheumatol. 2012;24:623-7.
    [CrossRef] [PubMed] [Google Scholar]
  35. , , , , , , et al. Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women. Geriatr Gerontol Int. 2014;15:969-76.
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , . Effects of home-based tele-exercise on sarcopenia among community-dwelling elderly adults: Body composition and functional fitness. Exp Gerontol. 2017;87:33-9.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , , . Sarcopenia as a risk factor of falls and fractures among older adults. Medicina. 2023;59:964.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , , , , et al. The relationships between physical performance, activity levels, and falls in older men. J Gerontol A Biol Sci Med Sci. 2019;74:1475-83.
    [CrossRef] [PubMed] [Google Scholar]
  39. , , , , , , et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26:2793-802.
    [CrossRef] [PubMed] [Google Scholar]
  40. . Modern biological theories of aging. Aging Dis. 2010;1:72-4.
    [Google Scholar]
  41. . Human ageing, longevity and evolution: Can ageing be programmed? Anthropol Rev. 2019;82:417-33.
    [CrossRef] [Google Scholar]
  42. , , , , , . Old age as a privilege of the “selfish ones”. Aging Dis. 2010;1:139-46.
    [Google Scholar]
  43. , , . Understanding muscle regenerative decline with aging: New approaches to bring back youthfulness to aged stem cells. FEBS J. 2020;287:406-16.
    [CrossRef] [PubMed] [Google Scholar]
  44. , , . Muscle changes in aging: Understanding sarcopenia. Sports Health. 2014;6:36-40.
    [CrossRef] [PubMed] [Google Scholar]
  45. , . Role of muscle stem cells in sarcopenia. Curr Opin Clin Nutr Metab Care. 2017;20:186-90.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , . Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004;7:405-10.
    [CrossRef] [PubMed] [Google Scholar]
  47. . Physical inactivity in Saudi Arabia revisited: A systematic review of inactivity prevalence and perceived barriers to active living. Int J Health Sci (Qassim). 2018;12:50-64.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , . Caffeine, lactic acid, or nothing: What effect does expectation have on men's performance and perceived exertion during an upper body muscular endurance task? Int J Health Sci (Qassim). 2023;17:39-42.
    [Google Scholar]
  49. . Low levels of Vitamin D an emerging risk for cardiovascular diseases: A review. Int J Health Sci (Qassim). 2017;11:71-6.
    [Google Scholar]
  50. . Knee osteoarthritis related pain: A narrative review of diagnosis and treatment. Int J Health Sci (Qassim). 2014;8:85-104.
    [CrossRef] [PubMed] [Google Scholar]
  51. , . Barriers of physical assessment skills among nursing students in Arab Peninsula. Int J Health Sci (Qassim). 2018;12:58-66.
    [Google Scholar]
Show Sections